Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: An ethnomedicine from Andaman Islands

Virology Journal

Volumn 9, Issue , 2012, Pages

  Bag, Paromita ^a   Chattopadhyay, Debprasad ^a   Mukherjee, Hemanta ^a   Ojha, Durbadal ^a   Mandal, Nilanjan ^a   Sarkar, Mamta Chawla ^b   Chatterjee, Tapan ^c   Das, Gobardhan ^d   Chakraborti, Sekhar ^a,b  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^c JADAVPUR UNIVERSITY   (India)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Antiviral activity; Ethnomedicine; Herpes simplex virus; Mallotus peltatus; Ursolic acid

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FRACTION A; MALLOTUS PELTATUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; URSOLIC ACID;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IMMUNOFLUORESCENCE; MALLOTUS; MALLOTUS PELTATUS; MEDICINAL PLANT; NONHUMAN; POLYMERASE CHAIN REACTION; PROTON NUCLEAR MAGNETIC RESONANCE; TRADITIONAL MEDICINE; VERO CELL;

ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; EUPHORBIACEAE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; MEDICINE, TRADITIONAL; PLANT EXTRACTS; PLANTS, MEDICINAL; TRITERPENES; VERO CELLS; VIRAL PLAQUE ASSAY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 84861332602     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-98     Document Type: Article

References (60)

1. The role of anti-HSV therapeutics in the HIV-infected host and in controlling the HIV epidemic. Barton S, Herpes 2005 12 15 22 16026640
2. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. Fatahzadeh M, Schwartz RA, J Am Acad Dermatol 2007 57 5 737 763 10.1016/j.jaad.2007.06.027 17939933
3. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Cowan FM, French RS, Mayaud P, Gopal R, Robinson NJ, de Oliveira SA, Faillace T, Uusküla A, Nygård-Kibur M, Ramalingam S, Sridharan G, El Aouad R, Alami K, Rbai M, Sunil-Chandra NP, Brown DW, Sex Transm Infect 2003 79 4 286 290 10.1136/sti.79.4.286 12902576
4. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landry B, Mills J, N Engl J Med 1991 325 8 551 555 10.1056/NEJM199108223250805 1649971
5. Reciprocal transactivation between HIV-1 and other human viruses. White MK, Gorrill TS, Khalili K, Virology 2006 352 1 13 10.1016/j.virol.2006.04.006 16725168
6. Synergistic interactions between herpes simplex virus type-2 and human immunodeficiency virus epidemics. Wald A, Herpes 2004 11 70 76 15960904
7. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. Mbopi-Kéou FX, Grésenguet G, Mayaud P, Weiss HA, Gopal R, Matta M, Paul JL, Brown DW, Hayes RJ, Mabey DC, Bélec L, J Infect Dis 2000 182 4 1090 1096 10.1086/315836 10979904
8. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. Nagot N, Ouédraogo A, Foulongne V, Konaté I, Weiss HA, Vergne L, Defer M-C, Djagbaré SA, Andonaba J-B, Becquart P, Segondy M, Vallo R, Sawadogo A, Van de Perre P, Mayaud P, N Engl J Med 2007 356 790 799 10.1056/NEJMoa062607 17314338
9. Herpes simplex virus resistance to antiviral drugs. Morfin F, Thouvenot D, J Clin Virol 2003 26 1 29 37 10.1016/S1386-6532(02)00263-9 12589832
10. Task Force on Herpes Simplex Virus Resistance, Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Reyes M, Shaik NS, Graber JM, Nisenbaum R, Wetherall NT, Fukuda K, Reeves WC, Arch Intern Med 2003 163 1 76 80 10.1001/archinte.163.1.76 12523920
11. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Miserocchi E, Modorati G, Galli L, Rama P, Am J Ophthalmol 2007 144 4 547 551 10.1016/j.ajo.2007.06.001 17692271
12. A purine nucleoside analogue-acyclovir [9-(2-hydroxyethoxymethyl)-9h- guanine] reversibly impairs testicular functions in mouse. Narayana K, J Toxicol Sci 2008 33 1 61 70 10.2131/jts.33.61 18303185
13. Renal function after acyclovir intravenous injection. Brigden D, Rosling AE, Woods NC, Am J Med 1982 73 1A 182 185 6285711
14. Acyclovir-induced renal failure Clinical course and histology. Sawyer MH, Webb DE, Balow JE, Straus SE, American J Med 1988 84 6 1067 1071 10.1016/0002-9343(88)90313-0
15. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Stanberry LR, Herpes 2004 11 A 161 169
16. Vaccines for herpes simplex virus infections. Koelle DM, Curr Opin Investig Drugs 2006 7 136 141 16499283
17. Ethnomedicines and ethnomedicinal phytophores against Herpesviruses. Chattopadhyay D, Khan MTH, Biotechnol Annu Rev 2008 14 297 348 18606369
18. Ethnobotanical studies of the tribes of Andaman and Nicobar Islands India I Onge. Bhargava N, Econ Bot 1983 37 110 119 10.1007/BF02859311
19. Plant folk medicines among Nicobarese of Katchal Island, India. Dagar HS, Dagar JC, Econ Bot 1991 45 114 119 10.1007/BF02860056
20. Antimicrobial and anti-inflammatory activity of Mallotus peltatus leaf extract. Chattopadhyay D, Arunachalam G, Mandal AB, Sur TK, Mandal SC, Bhattacharya SK, J Ethnopharmacol 2002 82 229 237 10.1016/S0378-8741(02)00165-4 12242000
21. Analgesic and Antiinflammatory Activity of Alstonia macrophylla and Mallotus peltatus leaf extracts: two popular ethnomedicines of Onge, a Negrito tribe of little Andaman. Chattopadhyay D, Arunachalam G, Sur TK, Bhattacharya SK, Mandal AB, Oriental Pharm Exp Med 2005 5 2 124 136
22. Pharmacological activities of three Ethnomedicines of Little Andaman. Chattopadhyay D, Arunachalam G, Mandal AB, Bhattacharya SK, Recent progress in Medicinal Plants, Search for natural Drugs Studium Press LLC, Houston, Govil JN, Singh VK, Arunachalam C, 2006 511 537
23. Antimicrobial activity of Alstonia macrophylla: folklore of Bay Islands. Chattopadhyay D, Maiti K, Kundu AP, Chakrabarty MS, Bhadra R, Mandal SC, Mandal AB, J Ethnopharmacol 2001 77 49 55 10.1016/S0378-8741(01)00264-1 11483378
24. Pollock JRA, Stevens R, Dictionary of Organic Compounds, Volume 5 Eyre and Spottiswoode, London 4 1965
25. Genital herpes-how much of a public-health problem? Mindel A, Lancet 1988 351 16 18
26. Inhibitory effect of anti-pyretic and anti-inflammatory herbs on herpes simplex virus replication. Hsiang CY, Hsieh CL, Wu SL, Lai IL, Ho TY, Am J Chin Med 2001 29 3-4 459 467 11789588
27. Cytotoxicity and viability. Wilson Anne P, Animal Cell Culture: A Practical Approach Oxford University Press, Oxford, Masters John RW, 3 2000 Chapter 7. ISBN 978-0199637966
28. Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin-carbohydrate complex from Prunella vulgaris. Zhang Y, But P-H, Ooi E-CV, Xu H-Xi, Delaney GD, Lee Spencer HS, d Lee SF, Antiviral Research 2007 75 3 242 249 10.1016/j.antiviral.2007.03.010 17475343
29. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Mosmann T, J Immunol Methods 1983 65 1-2 55 63 6606682
30. Recent advancements for the evaluation of Antiviral activities of natural products. Chattopadhyay D, Chawla Sarkar M, Chatterjee T, Dey R, Bag P, Chakrabarty S, Khan MTH, New Biotechnology 2009 25 5 347 368 10.1016/j.nbt.2009.03.007 19464980
31. In vitro antiviral activities of Caesapinia pulcherrima and its related flavonoids. Chiang LC, Chiang W, Liu MC, Lin CC, J Antimicrob Chemother 2003 52 194 198 10.1093/jac/dkg291 12837746
32. Inhibition of herpes simplex virus type-1 multiplication by meliacine a peptide of plant origin. Villamil SM, Alche LE, Coto CE, Antivir Chem Chemother 1995 6 239 244
33. Antiviral activity of the Indian medicinal plant extract, Swertia chirata against herpes simplex viruses: a study by in vitro and molecular approach. Verma H, Patil PR, Kolhapure RM, Gopalkrishna V, Indian J Med Microbiol 2008 26 4 322 326 10.4103/0255-0857.43561 18974483
34. Evaluation of synergism or antagonism for the combined action of antiviral agents. Suhnel J, Antiviral Res 1990 13 23 39 10.1016/0166-3542(90) 90042-6 2334168
35. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 Se in combination with acyclovir against HSV type-1 in cell culture. Lawetz C, Liuzzi M, Antiviral Res 1998 39 35 46 10.1016/S0166-3542(98)00028-X 9754948
36. Comparative study of mechanism of herpes simplex virus in activation by sodium lauryl sulphate and n-lauroylsarcosine. Piret J, Roy S, Gagnon M, Antimicrob Agents Chemother 2002 46 2933 2942 10.1128/AAC.46.9.2933-2942.2002 12183250
37. Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage of replication of herpes simplex virus type 2 in vitro. Cheng HY, Lin TC, Yang CM, Wang KC, Lin LT, Lin CC, J Antimicrob Chemother 2004 53 577 583 10.1093/jac/dkh136 14998984
38. Evaluation of Antipyretic activity of leaf extracts of Mallotus peltatus (Geist) Muell. Arg.: A folk medicine. Chattopadhyay D, Arunachalam G, Mandal AB, Mandal SC, Phytomedicine 2002 9 632 635 10.1078/094471102321616445 12487327
39. New antiviral drugs that target herpesvirus helicase primase enzymes. Kleymann G, Herpes 2003 10 2 46 52 14577954
40. Sweetman S, The complete drug reference. 34th ed Pharmaceutical Press, London, Martindale, 2004 550 554 ISBN 0-85369
41. Mallotus. Rastogi RP, Compendium of Indian Medicinal Plants Publications & Informations Directorate, CSIR, New Delhi 1992 450
42. Sastri BN, Wealth of India, Raw Materials; Vol. 1A, 199-200 Publications & Information Directorate, CSIR, New Delhi 1985 1948 1976 16087633
43. The cytotoxic principle of Hyptis capitata and structure of new triterpene hyptatica acid A and B. Yamagishi T, Zhang DC, Chang JJ, Phytochemistry 1988 27 321 3 6
44. Anticancer Activities of Plant Triterpenoids, Ursolic acid and Oleanoid acid. Kim KW, J Korean Assoc Cancer Prev 1997 2 38 44
45. Antitumor and antimetastatic activities of ursolic acid. Kim SH, Song GY, Ryu SY, Korean J Oriental Med Pathol 1999 13 65 75
46. Structure of ursolic acid ethanol solvate. Simon A, Delage C, Saux M, Chulia A, Najida A, Rigaud M, Acta Crystallogr C 1992 48 726 728 10.1107/S0108270191012581
47. Present status on cancer chemoprevention in Japan. Muto Y, Ninomiya M, Fujiki H, Jpn J Clin Oncol 1990 20 219 224 2255099
48. Anti-AIDS Agents. 30 anti-HIV activity of oleanolic acid. Promolic acid and structurally related triterpenoids. Kashiwada Y, Wang HK, Nagao T, J Natural Product 1998 61 1090 1095 10.1021/np9800710
49. Antibiotic action of ursolic acid. Kowalewski Z, Kortus M, Edzia W, Koniar H, Arch Immunol et Ther Exp (Warsz) 1976 24 115 119
50. Evaluation of antiinflammatory activity of Alstonia macrophylla wall ex A.DC. Leaf extract. Arunachalam G, Chattopadhyay D, Mandal AB, Sur TK, Mandal SC, Phytomedicine 2002 9 727 730 10.1078/094471102321621331 12587693
51. Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. Najid A, Simon A, Cook J, Chable-Rabinobitch H, Delage C, Chulia A, Riguad M, FEBS Lett 1992 229 213 217
52. Ursolic acid from Plantago major, a selective inhibition of cyclooxygenase-2 catalyzed prostaglandin biosynthesis. Ringbom T, Segura L, Noreem Y, Perera P, Bohlin L, J Nat Prod 1998 61 1212 1215 10.1021/np980088i 9784154
53. Selective inhibition of cyclic AMP-Dependent protein kinase by amphiliphilic triterpenoids and related compounds. Wang BH, Polya GM, Phytochemistry 1996 41 55 63 10.1016/0031-9422(95)00583-8 8588874
54. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Mizushina Y, Iida A, Ohta K, Sugawara F, Sakaguchi K, Biochem J 2000 350 757 763 10.1042/0264-6021:3500757 10970789
55. The antioxidative mechanism of ursolic acid. Kim JS, Huh JI, Song SH, Korean J Gerontol 1996 6 52 56
56. Apoptotic activity of ursolic acid may correlate with the inhibition of DNA replication. Kim DK, Baek JH, Kang CM, Int J Cancer 2000 87 629 636 10.1002/1097-0215(20000901)87:5<629::AID-IJC2>3.0.CO;2-P 10925354
57. Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells. Choi YH, Baek JH, Yoo MA, Chung HY, Kim ND, Kim KW, Int J Oncol 2000 17 565 571 10938399
58. Ursolic acid as a trypanocidal constituent in rosemary. Abe F, Yamauchi T, Nagao T, Kinjo J, Okabe H, Higo H, Akahane H, Biol Pharm Bull 2002 25 1485 1487 10.1248/bpb.25.1485 12419966
59. Anti-herpes simplex virus activity of extracts from the culinary herbs Ocimum sanctum L., Ocimum basilicum L. and Ocimum americanum L. Yucharoen R, Anuchapreeda S, Tragoolpua Y, Afr J Biotechnol 2011 10 5 860 866
60. Katsuo M, Hiroki T, Norio F, Yasutomo N, Yukiko Y, Photoaging inhibitor and dermal agent for external use, 1997 Japanese Patent No. 09143050